“After many intensive discussions, we are very pleased to announce that Rupert J. Haynes has joined HAPA’s Advisory Board in May 2023,” said Ricardo Pendon, CEO of HAPA. The bioindustry expert’s decision to join our team solidifies HAPA’s position as one of the top players in the industry. Haynes, an esteemed bioindustry expert, brings a
We are excited to announce that HAPA is now a member of the European Medicinal Cannabis Association (EUMCA). The EUMCA is the authoritative voice for the medicinal cannabis industry sector in Europe, and we are proud to now be a part of this important organization. Sita Schubert, the founder and general secretary of the EUMCA,
Dear Investors, we appreciate your continued support and interest in HAPA pharm. We are pleased to share with you the latest developments of our company and our future plans.
After thorough selection and planning, HAPA pharm is proud to announce the composition of its Advisory Board. The board consists of recognized experts from various fields who have joined at different times:
Raphael Mechoulam was born in Sofia, Bulgaria, on November 5, 1930. The son of Jewish immigrants from Bulgaria, he grew up in Israel. He studied at the Hebrew University of Jerusalem, where he later began his career as a scientist. After completing his studies in 1952, Mechoulam worked as an officer in the Israeli army
Dortmund, January 2023 – HAPA Pharm GmbH is expanding its management team: from January 2023, industry pioneer Alexander Rieg will support the internationally active company as Chief Operating Officer. Alexander Rieg has been an integral part of the medical cannabis industry in Germany for years. Not only is he the founder of `GECA Pharma GmbH’,
Corporate development with international expertise. From January 2023, Dr. Malgorzata Meunier will be Chief Strategy Officer responsible for product development as well as overseeing the European market development of the internationally operating company. Prior to specializing in medical cannabis, Dr. Malgorzata Meunier spent the last 18 years in several international pharmaceutical companies in France and
This content is currently only available in German.
Lieber Arzt, Lieber Apotheker,
im Passwort-geschützten Bereich unserer Website haben wir zahlreiche wertvolle Artikel für Sie zur Verfügung gestellt. Unter anderem finden Sie Informationen zu folgenden Themen:
